ASSESSMENT OF TISSUE PERMEABILITY ON DYNAMIC MAGNETIC CONTRAST ENHANCEMENT MAGNETIC RESONANCE IN PROSTATE CANCER DIAGNOSIS
Main Article Content
Abstract
Purpose: The aims of this study was to evaluate tissue permeability on dynamic contrast-enhanced MRI in the diagnosis of prostate cancer (PC). Material and Methods: A cross-sectional descriptive study was conducted on 39 patients with suspected PC at Hanoi Medical University Hospital from April 2023 to July 2024. Patients underwent multiparametric prostate MRI with dynamic contrast-enhancement (DCE) pulse sequence to evaluate tissue permeability. Results: Of the total 39 patients enrolled in the study, 51.3% were diagnosed with PC and 48.7% were diagnosed with benign tumors. Most patients diagnosed with PC (95.0%) had limited DWI/ADC diffusion and early enhancement on DCE pulses (90%). Among the tissue permeability parameters, K-trans and Kep are two highly valuable parameters in the diagnosis of PC. At the cut-off of 0.382 for K-trans and 1.146 for Kep, the sensitivity and specificity were 90% and 94.2% for Ktrans, 95% and 94.7% for Kep, respectively. Conclusion: Tissue permeability parameters on dynamic contrast-enhancement MRI have high value in diagnosing prostate cancer.
Article Details
Keywords
Prostate cancer, Dynamic contrast-enhanced MRI, tissue permeability.
References
2. Alghamdi D, Kernohan N, Li C, Nabi G. Comparative Assessment of Different Ultrasound Technologies in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2023;15(16): 4105. doi:10.3390/ cancers15164105
3. Giá trị cộng hưởng từ khuếch tán trong chẩn đoán ung thư tuyến tiền liệt | Hội Điện Quang và Y Học Hạt Nhân. April 1, 2017. Accessed July 20, 2023. https://www.radiology. com.vn/bao-cao-khoa-hoc/gia-tri-cong-huong-tu-khuech-tan-trong-chan-doan-ung-thu-tuyen-tien-liet-n379.html
4. Chatterjee A, He D, Fan X, et al. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer. Acad Radiol. 2018;25(3):349-358. doi:10.1016/j.acra.2017.10.004
5. Xu S, Liu X, Zhang X, et al. Prostate zones and tumor morphological parameters on magnetic resonance imaging for predicting the tumor-stage diagnosis of prostate cancer. Diagn Interv Radiol. 2023; 29(6): 753-760. doi:10.4274/dir. 2023.232284
6. Ma XZ, Lv K, Sheng JL, et al. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer. Oncol Lett. 2019;17(3):3077-3084. doi:10.3892/ol.2019.9988
7. Zhang Y, Li Z, Gao C, et al. Preoperative histogram parameters of dynamic contrast‐enhanced MRI as a potential imaging biomarker for assessing the expression of Ki‐67 in prostate cancer. Cancer Med. 2021;10(13):4240-4249. doi:10.1002/cam4.3912
8. Sun H, Du F, Liu Y, Li Q, Liu X, Wang T. DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml. Front Oncol. 2022;12:925186. doi:10.3389/fonc.2022.925186